Children with cerebral palsy show long-term improvement through treatment with botulinum toxin, according to research presented during the American Academy of Neurology Annual Meeting in Honolulu, March 29-April 5, 2003.
Researchers in Honolulu have found a correlation between high fruit and fruit drink consumption and risk of Parkinson's disease. Findings of their study are being presented at the American Academy of Neurology Annual Meeting in Honolulu.
Requiring doctors to report their patients' seizures to the state can lead patients to withhold information from their doctors and can harm the doctor-patient relationship, according to research presented during the American Academy of Neurology Annual Meeting in Honolulu, March 29-April 5, 2003.
Seven abstracts have been selected for the Late Breaking Science session at the American Academy of Neurology Annual Meeting in Honolulu, March 29-April 5, 2003. The Late Breaking Science Program highlights the most current research.
Researchers from Beth Israel Medical Center in New York have demonstrated that deep brain stimulation of the globus pallidus (near the thalamus) is a safe and highly effective therapy in patients with generalized torsion dystonia.
Levodopa is the most effective treatment for Parkinson's disease, but some laboratory studies have raised concern that it may hasten disease progression. Those fears appear to have been laid to rest by the clinical results of a large double-blind study.
A very high proportion of patients with juvenile-onset insulin-dependent diabetes mellitus have been found to also have cerebral atrophy, or a loss of brain tissue, according to a recent study conducted at the Department of Neurology, State University of New York at Buffalo.
In developing countries, where epilepsy surgery facilities, technology and expertise are limited, researchers have sought to identify factors most predictive of excellent results among candidates for epilepsy surgery. Findings from research conducted in Kerala, India, are being presented at the American Academy of Neurology Annual Meeting.
People with high blood pressure, large waistlines and other risk factors called metabolic syndrome are more likely to suffer a stroke, according to research presented during the American Academy of Neurology Annual Meeting in Honolulu, March 29-April 5, 2003.
Viral encephalitis causes a wider spectrum of movement disorders than previously recognized, and treating them may require prolonged hospitalization, according to a study to be presented during the American Academy of Neurology Annual Meeting in Honolulu.
The neurological effects of bioterrorism and the history of biological warfare will be examined at the American Academy of Neurology 55th Annual Meeting taking place this week in Honolulu.
Researchers in New Orleans have identified a subset of stutterers that may benefit most from delayed auditory feedback, a technique by which the original acoustic speech signal is artificially modified and then fed back via headphones.
Using an electrical brain stimulator can improve the quality of life for Parkinson's disease patients long term, according to research presented during the American Academy of Neurology Annual Meeting in Honolulu, March 29-April 5, 2003.
More evidence shows that West Nile virus can cause a polio-like syndrome with paralysis and impaired breathing. Researchers conducted tests on the bodies of four people who died after developing polio-like symptoms along with West Nile virus infections.
Simvastatin, a cholesterol-lowering drug, has shown promise in treating the most common form of MS, according to researchers from Barrow Neurological Institute in Phoenix. Results of their study are being presented at AAN Annual Meeting in Honolulu.
Researchers from Chicago have identified focal neurological deficits as a major group of presenting symptoms among patients with West Nile Virus infection, which became epidemic in the United States in 2002.
Researchers at New York University have found that immunization prolongs the incubation period for prion diseases such as Creutzfeldt-Jakob disease and may have therapeutic value for other neurodegenerative illness such as Alzheimer's disease.
Researchers have found evidence that non-steroidal anti-inflammatory drugs (NSAIDs) may exert a protective effect against the risk of Alzheimer's disease. Results of the multiple-study analysis will be presented at AAN's Annual Meeting in Honolulu.
Researchers have shown that bone marrow-derived stem cells contribute to the regeneration of central nervous system, cardiac and skeletal muscle in mice with an animal version of amyotrophic lateral sclerosis (ALS).
A cross-sectional study has convinced some researchers that the APOE genotype is a risk factor for diabetic neuropathy severity equal to having 15 extra years of age or diabetes duration.
A multi-center study of 97 patients found that 72 percent of those who reported premonitory symptoms (Fatigue, difficulty concentrating and a stiff neck) experienced a migraine within 72 hours at least half the time.
Finding the answers on how to tailor life-saving treatments for hemorrhagic stroke is one of the research areas supported by the 10-year old AAN Foundation.
The first observational study of whiplash injury to use a control group has shown that the intensity of whiplash pain is low, but its frequency is high, and compared to similar types of pain from ankle injury, it lasts longer and produces more disability.
Women who consume little or no caffeine, but who take hormone replacement therapy, may reduce their risk of developing Parkinson's disease, according to a study.
Two America-based medical researchers whose work is central to progress in understanding Alzheimer's disease are co-winners of the 2003 Potamkin Prize for Research in Picks, Alzheimer's Disease and Related Disorders, awarded by the American Academy of Neurology.
The journal Neurology, the American Academy of Neurology's twice-monthly scientific journal for neurologists and neuroscientists, has recently launched a new feature tailored for the layperson called the Patient Page.
The American Academy of Neurology Foundation has named Jerry Lewis the recipient of its 2003 Public Leadership in Neurology Award. Lewis is being recognized for his unparalleled efforts on behalf of the Muscular Dystrophy Association and the patients and researchers it represents.
The AAN annual meeting is the unsurpassed source for learning what's new and newsworthy in global neurological research and understanding. It is in Honolulu March 29-April 5.
Child neurologists with the American Academy of Neurology and the Child Neurology Society have released new practice guidelines recommending tests that should be used to diagnose even the youngest children with global developmental delay.
A new evidence-based practice guideline developed by the American Academy of Neurology and the Child Neurology Society recommends that physicians avoid routinely treating a child's first unprovoked seizure with antiepileptic drugs.
Contrary to common belief, early successful treatment and control of epileptic seizures with appropriate medications does not necessarily guarantee that seizures will always be controlled by those medications in the future, according to a study.
HIV-infected patients with cognitive impairment are more likely to fail to take their medications than those without cognitive impairment, according to a study.
High dietary intakes of total fat, saturated and trans fats and cholesterol have long been associated with such health risk factors as heart disease, obesity, diabetes, and several forms of cancer.
A recent study has confirmed what medical professionals and loved ones of people with Parkinson's disease have long feared to be true -- the likelihood of a driving mishap increases in direct correlation with Parkinson's disease progression.
As many as one in 10 people in developing countries are carriers of the pork tapeworm taenia solium. This tapeworm's prevalence is becoming increasingly common in more developed countries due to immigration, poverty, and areas of poor hygiene or minimum sanitation services.
Care of people with Alzheimer¡œs disease is a challenging task but can be improved, according to seven medical organizations that met to discuss strengths and potential pitfalls in the diagnosis and treatment of Alzheimer's disease.
An anticonvulsant drug typically used to control seizures and neuropathic pain may reduce symptoms among those who suffer from restless legs syndrome, a movement disorder that affects up to 10 percent of the population.
As in the United States, United Kingdom veterans who were deployed to the Gulf War in 1990 to 1991 have reported a higher prevalence of neuromuscular symptoms than soldiers who served elsewhere.
There is a serious under-recognition of stroke in the neonate and child, and risk factors and appropriate treatment strategies remain largely unidentified, according to the chief neurologist at the University of California-San Francisco Department of Neurology.
In a first study of its kind, researchers tested the hypothesis that improving cerebrospinal fluid turnover will slow or stop the progression of dementia in people with Alzheimer's disease. Researchers from Stanford University, University of Washington, and the Barrow Neurological Institute in Phoenix, have published the conclusions of their study.
Previous research has implicated oxidative damage (cell degradation) in the development of Parkinson's disease. Because vitamins E, C and carotenoids are antioxidants, researchers recently studied the associations between their intake and risk of Parkinson's disease. Their conclusions point not to supplements, but to dietary intake of vitamin E (from the foods we eat) as having a protective factor in the risk of developing Parkinson's disease.
Seven leading U.S. child neurologists are gathering in San Francisco, Thurs., Oct. 24, to share the latest research and new physician guidelines pertaining to neurological disorders affecting children. Topics will include mental etardation, febrile seizures, autism, epilepsy, brain injury, and cerebral palsy.
A group of cholesterol-lowering drugs may also effectively interfere with the progression of multiple sclerosis (MS). These drugs, known as statins, greatly reduce hardening of the arteries (atherosclerosis) and heart disease, mainly by their cholesterol and low-density lipoprotein-lowering properties.
Opioids -- narcotic analgesics -- have recently been shown to be effective in treating post-herpetic neuralgia. Post-herpetic neuralgia is a painful chronic condition that can develop following a case of shingles, especially in older patients or those with immunodeficiencies.
Have researchers found yet another reason to take an aspirin a day? Aspirin has been found to benefit cardiac patients. Now a new study presents additional evidence that regular use of aspirin and other non-steroidal anti-inflammatory drugs may reduce the incidence of dementia in elderly people, but only when taken for more than two years.
Researchers analyzing the records of 1,378 patients from three clinical trials of mitoxantrone as a treatment for multiple sclerosis (MS) reveal a small, but significant risk for developing diminished left ventricular ejection fraction (LVEF), which is a decrease in function of the left ventrical, and a lesser risk for congestive heart failure following treatment. The study is reported in the latest issue of Neurology, the scientific journal of the American Academy of Neurology.
A new study challenges previous findings that patients undergoing elective coronary bypass grafting, or valve replacement, experience long-term cognitive decline. According to the study, that's not always the case.
Patients with motor neuron disease, including ALS, were significantly more likely to been slim and to have been varsity athletes, according to a new study conducted by Nikolaos Scarmeas and a team of epidemiologists from Columbia University.